MACROCYCLIC BLOCKERS FOR USE IN THE REDUCTION OF PERIPHERAL SIDE EFFECTS DUE TO EVEROLIMUS THERAPY
WO2026060005A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name MONTARA THERAPEUTICS INC [US].
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
WO2026060005A1 · Application publication visible